388 related articles for article (PubMed ID: 37264402)
1. The role of m6A methylation in therapy resistance in cancer.
Zhuang H; Yu B; Tao D; Xu X; Xu Y; Wang J; Jiao Y; Wang L
Mol Cancer; 2023 Jun; 22(1):91. PubMed ID: 37264402
[TBL] [Abstract][Full Text] [Related]
2. The role of N6-methyladenosine (m6A) in eye diseases.
Gao JF; Zhang L
Mol Biol Rep; 2021 Aug; 48(8):6145-6150. PubMed ID: 34331665
[TBL] [Abstract][Full Text] [Related]
3. The role of m6A RNA methylation in cancer.
Sun T; Wu R; Ming L
Biomed Pharmacother; 2019 Apr; 112():108613. PubMed ID: 30784918
[TBL] [Abstract][Full Text] [Related]
4. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
Lin H; Wang Y; Wang P; Long F; Wang T
Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
[TBL] [Abstract][Full Text] [Related]
5. The Epigenetic Regulation of RNA N6-Methyladenosine Methylation in Glycolipid Metabolism.
Yang H; Li Y; Huang L; Fang M; Xu S
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830642
[TBL] [Abstract][Full Text] [Related]
6. Functions of N6-methyladenosine and its role in cancer.
He L; Li H; Wu A; Peng Y; Shu G; Yin G
Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
[TBL] [Abstract][Full Text] [Related]
7. N6-methyladenosine functions and its role in skin cancer.
Ran Y; Yan Z; Jiang B; Liang P
Exp Dermatol; 2023 Jan; 32(1):4-12. PubMed ID: 36314059
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications.
Wang D; Zhang Y; Li Q; Zhang A; Xu J; Li Y; Li W; Tang L; Yang F; Meng J
Biomed Pharmacother; 2023 Nov; 167():115477. PubMed ID: 37696088
[TBL] [Abstract][Full Text] [Related]
9. The functions of N6-methyladenosine (m6A) RNA modifications in colorectal cancer.
Qiao H; Liu L; Chen J; Shang B; Wang L
Med Oncol; 2022 Sep; 39(12):235. PubMed ID: 36175777
[TBL] [Abstract][Full Text] [Related]
10. N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives.
Xu Z; Peng B; Cai Y; Wu G; Huang J; Gao M; Guo G; Zeng S; Gong Z; Yan Y
Biochem Pharmacol; 2020 Dec; 182():114258. PubMed ID: 33017575
[TBL] [Abstract][Full Text] [Related]
11. The Role of m6A-Mediated DNA Damage Repair in Tumor Development and Chemoradiotherapy Resistance.
Qu L; Liu SJ; Zhang L; Liu JF; Zhou YJ; Zeng PH; Jing QC; Yin WJ
Cancer Control; 2024; 31():10732748241247170. PubMed ID: 38662732
[TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine (m6A) modification in gynecological malignancies.
Zhang C; Liu N
J Cell Physiol; 2022 Sep; 237(9):3465-3479. PubMed ID: 35802474
[TBL] [Abstract][Full Text] [Related]
13. [Research Progress of m6A Methylation Modification in Hematological Tumors--Review].
Li F; Yang FF; Xu YL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1607-1611. PubMed ID: 36208274
[TBL] [Abstract][Full Text] [Related]
14. The potential regulatory role of RNA methylation in ovarian cancer.
Zhao S; Zhang M; Zhu X; Xing J; Zhou J; Yin X
RNA Biol; 2023 Jan; 20(1):207-218. PubMed ID: 37194218
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer.
Liang Z; Kidwell RL; Deng H; Xie Q
Cancer Biol Med; 2020 Feb; 17(1):9-19. PubMed ID: 32296573
[TBL] [Abstract][Full Text] [Related]
16. The interplay between m6A RNA methylation and noncoding RNA in cancer.
Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z
J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221
[TBL] [Abstract][Full Text] [Related]
17. Research progress on N6-methyladenosine in the human placenta.
Zhou W; Xue P; Yang Y; Xia L; Yu B
J Perinat Med; 2022 Oct; 50(8):1115-1123. PubMed ID: 35606944
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of RNA modification N6-methyladenosine in human cancer.
Zhou Z; Lv J; Yu H; Han J; Yang X; Feng D; Wu Q; Yuan B; Lu Q; Yang H
Mol Cancer; 2020 Jun; 19(1):104. PubMed ID: 32513173
[TBL] [Abstract][Full Text] [Related]
19. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
Wei K; Gao Y; Wang B; Qu YX
Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
[TBL] [Abstract][Full Text] [Related]
20. RNA N-6-methyladenosine enzymes and resistance of cancer cells to chemotherapy and radiotherapy.
Xiang M; Liu W; Tian W; You A; Deng D
Epigenomics; 2020 May; 12(9):801-809. PubMed ID: 32515221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
